| # | Drug | Count |
|---|---|---|
| 0 | LEVETIRACETAM | 353 |
| 1 | LEVETIRACETAM IN SODIUM CHLORIDE | 331 |
| 2 | LEVETIRACETAM INJECTION | 331 |
| 3 | LEVETIRACETAM ORAL | 331 |
| 4 | LAMIVUDINE AND ZIDOVUDINE | 278 |
| 5 | RITONAVIR | 261 |
| 6 | LAMIVUDINE | 225 |
| 7 | FOLIC ACID | 223 |
| 8 | LOPINAVIR AND RITONAVIR | 203 |
| 9 | LAMIVUDINE ORAL | 190 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LAMIVUDINE AND ZIDOVUDINE | 278 | 0.0361 |
| 1 | NELFINAVIR MESYLATE | 55 | 0.0263 |
| 2 | EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 1 | 0.0213 |
| 3 | LOPINAVIR AND RITONAVIR | 203 | 0.0151 |
| 4 | HYDROXYPROGESTERONE CAPROATE | 2 | 0.0150 |
| 5 | NEVIRAPINE | 135 | 0.0150 |
| 6 | ZIDOVUDINE | 151 | 0.0146 |
| 7 | MEFLOQUINE HYDROCHLORIDE | 2 | 0.0128 |
| 8 | L-PHENYLALANINE | 1 | 0.0127 |
| 9 | VITAMINS AND MINERALS | 1 | 0.0112 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 261 | 0.0109 |
| 1 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 492 | 0.0100 |
| 2 | Protease Inhibitor [EPC] | 431 | 0.0097 |
| 3 | Oxytocic [EPC] | 26 | 0.0085 |
| 4 | Cytochrome P450 3A Inhibitor [EPC] | 432 | 0.0071 |
| 5 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 756 | 0.0069 |
| 6 | Prostaglandin E1 Analog [EPC] | 73 | 0.0044 |
| 7 | Anthelmintic [EPC] | 9 | 0.0031 |
| 8 | Vasopressin Receptor Agonist [EPC] | 1 | 0.0030 |
| 9 | CCR5 Co-receptor Antagonist [EPC] | 4 | 0.0017 |